Note 30.3 Research and development Details of expenditure incurred on approved in-house research and development facilities: (` cr) Particulars 2024-25 2023-24 Capital expenditure 4.22 57.60 Recurring expenditure 36.87 33.96 41.09 91.56 Note 30.4 Related party disclosures Note 30.4 (A) Related party information Name of the related party and nature of relationship No. Name of the related party Description of relationship 01. Aagam Holdings Pvt Ltd Entity over which control exercised by Key Management Personnel 02. Crawford Bayley & Co1 03. Khaitan & Co 04. Rudolf Atul Chemicals Ltd Joint venture company 05. Rudolf GmbH Entity over which control exercised by Joint venture partner 06. Rudolf Singapore 07. Rudolf Hub 1922 S.r.l 08. Key Management Personnel Sunil Lalbhai Chairman and Managing Director Samveg Lalbhai Managing Director Bharathy Mohanan Whole-time Director and President - U&S Gopi Kannan Thirukonda Whole-time Director and CFO Vivek Gadre (from January 24, 2025) Whole-time Director Mukund Chitale (up to October 16, 2024) Non-executive Director Subhalakshmi Panse (up to March 26, 2025) Non-executive Director Baldev Arora (up to March 31, 2025) Non-executive Director Pradeep Banerjee Non-executive Director Rangaswamy Iyer Non-executive Director Sharadachandra Abhyankar Non-executive Director Sujal Shah Non-executive Director Praveen Kadle Non-executive Director Padmaja Chunduru (from January 24, 2025) Non-executive Director Amal Ltd Rajeev Kumar Managing Director Abhay Jadeja (up to March 31, 2024) Director Mahalakshmi Subramanian (up to August 04, 2024) Director Jyotin Mehta Director Dipali Sheth Director Drushti Desai Director Venkatraman Srinivisan Director Amal Speciality Chemicals Ltd Rajeev Kumar Managing Director Yogesh Vyas Director Ankit Mankodi Director Syamal De Director Abhay Jadeja (up to March 31, 2024) Director Mahalakshmi Subramanian (up to August 04, 2024) Director Atul Bioscience Ltd Prabhakar Chebiyyam Managing Director Ajit Dangi (up to October 18, 2024) Director Pramod Lele Director 272 272 Integrated Annual Report 2024-25
RkJQdWJsaXNoZXIy MjA2MDI2